Four pressing concerns drive research on liver diseases at Mount Sinai: the increase in chronic liver disease, the rapid growth of fatty liver disease throughout the population, the growing incidence of liver cancer and the shortage of organs for liver transplants. Basic, translational and clinical research in the Division of Liver Disease is geared toward finding solutions.
The division is particularly renowned for its leadership in the study of hepatic fibrosis, hepatocellular carcinoma, hepatitis C virus infection, primary biliary cirrhosis, and liver immunology.